Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Explaining the nuances of dry eye and available treatment options to patients can be a challenge, especially when it comes to asymptomatic patients. Two doctors discussed how they explain the different types of dry eye and how they talk about available treatment options.
➤ Editorial statement on the nomenclature for refractive lenticule extraction procedure ➤ First patient dosed in Phase 1/2 trial evaluating allogenic cell therapy for corneal edema ➤ IND granted to company investigating therapy for geographic atrophy ➤ Licensing agreement to develop neuroprotective drug ➤ Retinal imaging test detects increased risk for type of dementia ➤ ASCRS news and events
➤ FDA approves presbyopia drop ➤ FDA approves expanded capabilities on anterior segment diagnostic platform ➤ Phase 4 data presented for dry eye disease drug ➤ Extension study for investigational wet AMD treatment demonstrates safety, efficacy ➤ Reports suggest reproxalap NDA might not be approved ➤ Companies partner to develop gene therapy ➤ ASCRS news and events
➤ Positive Phase 3 results in trial investigating topical diabetic macular edema treatment ➤ Positive topline results in Phase 3 trials for retinal vein occlusion treatment ➤ IND filed for drug to treat neuropathic corneal pain ➤ Trial for ‘first-in-class anti-VEGF-complement dual targeting drug’ begins dosing patients ➤ Complimentary access to video journal ➤ ASCRS news and events
In the 20+ years since intracorneal ring segments were first introduced, there have been several advances, both in terms of techniques and materials. EyeWorld spoke with three physicians for the latest in the world of intracorneal ring segments.
Two experts discussed the risk for infections with lamellar corneal grafts, how patients may present, and how to deal with this complication.
Julie Schallhorn, MD, Cornea Editor, gave a preview of the articles in the Cornea section and shared some thoughts on managing complications.
Losartan is being studied as a potential treatment for corneal fibrosis and scarring. An ophthalmologist who has been conducting studies on the use of topical losartan spoke about the status of those studies, experience with off-label applications in human patients, and his thoughts about this option becoming more available.
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
➤ Update on safety review of geographic atrophy drug ➤ IND application accepted by FDA for wet AMD gene therapy ➤ Phase 2 trial planned for investigational neuropathic corneal pain treatment ➤ Interim Phase 2 data for sustained wet AMD treatment ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.